Key Takeaways The S&P 500 rose 3.3% on Monday, May 12, 2025, as investors reviewed a trade deal between the U.S. and China ...

CVS Health CVS shares have rallied nearly 38% so far this month, driven by the company’s stronger-than-expected first-quarter ...

A measure now on the floor of the Nebraska Legislature would address some practices by intermediaries called pharmacy benefit managers that pharmacists say are harming their businesses.

The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.

CVS owns CVS Caremark and Cigna owns Express Scripts, both of which operate as pharmacy benefit managers (PBM). Investors may be reacting to the executive order's potential to undercut PBM ...

Can prescription benefit managers, or PBMs, be eliminated from the U.S. drug pricing process? Seeking Alpha analysts weigh in. Read more here.

Generally speaking, other things being equal, firms with a high return on equity and profit retention, have a higher growth rate than firms that don’t share these attributes. CVS Health's ...

Other health insurers in the S&P 500, including Humana, Molina Healthcare and Cigna, saw their stock prices decline. Companies in the broader healthcare space, including Elevance Health, Centene and ...

Molina Healthcare and Cigna, saw their stock prices decline. Companies in the broader healthcare space, including Elevance Health, Centene and CVS Health, also retreated. UnitedHealth's suspended ...